Preladenant
From Self-sufficiency
| File:Preladenant.png | |
| Identifiers | |
|---|---|
| ATC code | none |
| PubChem | CID 10117987 |
| Chemical data | |
| Formula | C25H29N9O3 |
| Molar mass | 503.555 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Preladenant (SCH-420,814) is a drug developed by Schering-Plough which acts as a potent and selective antagonist at the adenosine A2A receptor. It is being researched as a potential treatment for Parkinson's disease.[1]
 |
This pharmacology-related article is a stub. You can help ssf by expanding it. |
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Furans
- Triazolopyrazolopyrimidines
- Piperazines
- Phenol ethers
- 2Fix
